SC
IDYA icon

Stempoint Capital’s IDEAYA Biosciences IDYA Stock Holding History

Stempoint Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-161,659
Closed -$5.59M – 97
2025
Q4 		$5.59M Sell
161,659
-210,166
-57% -$6.7M 0.96% 35
2025
Q3 		$10.1M Buy
371,825
+205,940
+124% +$4.98M 2.03% 12
2025
Q2 		$3.49M Buy
165,885
+98,886
+148% +$1.9M 1.12% 27
2025
Q1 		$1.1M Buy
+66,999
New +$1.43M 0.35% 42
2024
Q4 		– Sell
-132,703
Closed -$4.2M – 66
2024
Q3 		$4.2M Buy
132,703
+30,916
+30% +$1.17M 1.26% 26
2024
Q2 		$3.57M Buy
101,787
+14,394
+16% +$570K 1.05% 30
2024
Q1 		$3.83M Buy
+87,393
New +$3.76M 1.01% 29

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Stempoint Capital's IDYA Position: Q1 2026 in Review

Stempoint Capital sold out of IDEAYA Biosciences (IDYA) in Q1 2026, closing a stake of 161,659 shares — an estimated $5.59M sold.

Stempoint Capital first reported a position in IDYA in Q1 2024 and held it in 7 quarters. The position peaked at $10.1M in Q3 2025. 254 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Stempoint Capital reported no remaining IDEAYA Biosciences position as of Q1 2026 after selling out during the quarter.
  • Stempoint Capital sold 161,659 IDEAYA Biosciences shares in Q1 2026, an estimated $5.59M.
  • Stempoint Capital first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 7 quarters.
  • Stempoint Capital's IDEAYA Biosciences position peaked at $10.1M in Q3 2025.
  • 254 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Stempoint Capital's 13F filing for Q1 2026, filed 15 May 2026.